← Leaderboards
Charles S Fuchs
Brigham And Women'S Hospital
$37,354,862
Attributed
$37,354,862
Total exposure
38
Grants
37
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.6M · FY2007–22$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$74,083,842 · 40
By mechanism
P30$30,250,694 · 27
P50$20,264,619 · 5
R01$15,111,297 · 4
P01$3,872,015 · 1
U19$2,200,722 · 1
U10$1,651,535 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Lu Wang$991,790
- Edward Giovannucci$20,500,695
- Song Hong$9,372,608
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsResearch PersonnelProgramsFundingMemberGrantTranslational ResearchClinical TrialsCancer Center Support GrantBaseComprehensive Cancer CenterCollaborationsLeadershipAreaAnticancer ResearchCancer BiologyEvaluationScientistResource SharingBasic ScienceDesignYale Cancer CenterPreventionResources
Grant awards (161)
Leadership, Planning and Evaluation$655,583
P30 · FY2022 · CA · contact PI
Developmental Funds$470,948
P30 · FY2022 · CA · contact PI
Cancer Center Support Grant$327,124
P30 · FY2022 · CA · contact PI
Leadership, Planning and Evaluation$655,583
P30 · FY2021 · CA · contact PI
Developmental Funds$470,948
P30 · FY2021 · CA · contact PI
Leadership, Planning and Evaluation$655,583
P30 · FY2020 · CA · contact PI
Developmental Funds$470,948
P30 · FY2020 · CA · contact PI
Isolation and profiling of antibodies targeting SARS-CoV-2$327,490
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$188,862
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$150,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2020 · CA · contact PI
Cancer Center Support Grant$4,530,485
P30 · FY2019 · CA · contact PI
Yale Cancer Center NCTN LAPS$732,960
UG1 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$655,583
P30 · FY2019 · CA · contact PI
Developmental Funds$470,948
P30 · FY2019 · CA · contact PI
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival$428,382
R01 · FY2019 · CA · contact PI
Cancer Center Support Grant$250,000
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$115,000
P30 · FY2019 · CA · contact PI
Program 32: Gastrointestinal Malignancies$72,240
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$60,000
P30 · FY2019 · CA · contact PI
Developmental Funds$11,904
P30 · FY2019 · CA · contact PI
Leadership, Planning and Evaluation$11,904
P30 · FY2019 · CA · contact PI
Program 32: Gastrointestinal Malignancies$6,167
P30 · FY2019 · CA · contact PI
Cancer Center Support Grant$4,530,485
P30 · FY2018 · CA · contact PI
Yale Cancer Center NCTN$700,035
U10 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$655,583
P30 · FY2018 · CA · contact PI
Developmental Funds$470,948
P30 · FY2018 · CA · contact PI
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival$437,567
R01 · FY2018 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$410,019
R01 · FY2018 · CA · contact PI
Cancer Center Support Grant$250,000
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$250,000
P30 · FY2018 · CA · contact PI
Program 32: Gastrointestinal Malignancies$73,899
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$60,000
P30 · FY2018 · CA · contact PI
Cancer Center Support Grant$56,337
P30 · FY2018 · CA · contact PI
Developmental Funds$11,904
P30 · FY2018 · CA · contact PI
Developmental Funds$11,904
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$11,904
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$11,904
P30 · FY2018 · CA · contact PI
Program 32: Gastrointestinal Malignancies$11,430
P30 · FY2018 · CA · contact PI
Program 32: Gastrointestinal Malignancies$5,848
P30 · FY2018 · CA · contact PI
Program 32: Gastrointestinal Malignancies$5,123
P30 · FY2018 · CA · contact PI
Program 32: Gastrointestinal Malignancies$3,833
P30 · FY2018 · CA · contact PI
Developmental Funds$2,856
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$2,856
P30 · FY2018 · CA · contact PI
Leadership, Planning and Evaluation$2,682
P30 · FY2018 · CA · contact PI
Developmental Funds$2,682
P30 · FY2018 · CA · contact PI
Program 32: Gastrointestinal Malignancies$1,602
P30 · FY2018 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$2,600,006
P30 · FY2017 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$1,041,509
R01 · FY2017 · CA · contact PI
Yale Cancer Center NCTN$951,500
U10 · FY2017 · CA · contact PI
Developmental Funds$480,144
P30 · FY2017 · CA · contact PI
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival$467,689
R01 · FY2017 · CA · contact PI
Senior Leadership$316,965
P30 · FY2017 · CA · contact PI
Biostatistics$276,571
P30 · FY2017 · CA · contact PI
Administration$259,074
P30 · FY2017 · CA · contact PI
Clinical Trials Office$253,868
P30 · FY2017 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$250,000
P30 · FY2017 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$200,000
P30 · FY2017 · CA · contact PI
Administration, Evaluation, and Planning$190,670
P50 · FY2017 · CA · contact PI
Flow Cytometry$162,663
P30 · FY2017 · CA · contact PI
Yale Center for Genome Analysis$132,709
P30 · FY2017 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$125,625
P30 · FY2017 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$117,999
P30 · FY2017 · CA · contact PI
Yale Center for Molecular Discovery$102,497
P30 · FY2017 · CA · contact PI
Protocol Review and Monitoring System$90,849
P30 · FY2017 · CA · contact PI
Rapid Case Ascertainment$78,962
P30 · FY2017 · CA · contact PI
Data and Safety Monitoring/ NIH Policy$72,077
P30 · FY2017 · CA · contact PI
Cesium 137 Irradiator$70,921
P30 · FY2017 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$60,000
P30 · FY2017 · CA · contact PI
Yale Pathology Tissue Services$59,320
P30 · FY2017 · CA · contact PI
Protocol-Specific Research Support$53,722
P30 · FY2017 · CA · contact PI
Program 32: Gastrointestinal Malignancies$42,984
P30 · FY2017 · CA · contact PI
Planning and Evaluation$36,971
P30 · FY2017 · CA · contact PI
Signal Transduction Research Program$22,641
P30 · FY2017 · CA · contact PI
Radiobiology and Radiotherapy Research Program$22,641
P30 · FY2017 · CA · contact PI
Molecular Virology Research Program$22,641
P30 · FY2017 · CA · contact PI
Developmental Therapeutics Research Program$22,641
P30 · FY2017 · CA · contact PI
Cancer Immunology Research Program$22,641
P30 · FY2017 · CA · contact PI
Cancer Genetics and Genomics Research Program$21,078
P30 · FY2017 · CA · contact PI
Cancer Prevention and Control Research Program$18,410
P30 · FY2017 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$2,600,006
P30 · FY2016 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$502,500
P30 · FY2016 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$484,876
P30 · FY2016 · CA · contact PI
Developmental Funds$480,144
P30 · FY2016 · CA · contact PI
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival$464,372
R01 · FY2016 · CA · contact PI
Senior Leadership$316,965
P30 · FY2016 · CA · contact PI
Biostatistics$276,571
P30 · FY2016 · CA · contact PI
Administration$259,074
P30 · FY2016 · CA · contact PI
Clinical Trials Office$253,868
P30 · FY2016 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$200,000
P30 · FY2016 · CA · contact PI
Administration, Evaluation, and Planning$181,635
P50 · FY2016 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$175,531
R01 · FY2016 · CA · contact PI
Flow Cytometry$162,663
P30 · FY2016 · CA · contact PI
Yale Center for Genome Analysis$132,709
P30 · FY2016 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$125,625
P30 · FY2016 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$121,550
P30 · FY2016 · CA · contact PI
Yale Center for Molecular Discovery$102,497
P30 · FY2016 · CA · contact PI
Gastrointestinal Malignancies$93,190
P30 · FY2016 · CA · contact PI
Protocol Review and Monitoring System$90,849
P30 · FY2016 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$87,167
R01 · FY2016 · CA · contact PI
Rapid Case Ascertainment$78,962
P30 · FY2016 · CA · contact PI
Data and Safety Monitoring/ NIH Policy$72,077
P30 · FY2016 · CA · contact PI
Cesium 137 Irradiator$70,921
P30 · FY2016 · CA · contact PI
Yale Comprehensive Cancer Center Support Grant$60,000
P30 · FY2016 · CA · contact PI
Yale Pathology Tissue Services$59,320
P30 · FY2016 · CA · contact PI
Protocol-Specific Research Support$53,722
P30 · FY2016 · CA · contact PI
Planning and Evaluation$36,971
P30 · FY2016 · CA · contact PI
Developmental Therapeutics Research Program$22,641
P30 · FY2016 · CA · contact PI
Signal Transduction Research Program$22,641
P30 · FY2016 · CA · contact PI
Radiobiology and Radiotherapy Research Program$22,641
P30 · FY2016 · CA · contact PI
Molecular Virology Research Program$22,641
P30 · FY2016 · CA · contact PI
Cancer Immunology Research Program$22,641
P30 · FY2016 · CA · contact PI
Cancer Genetics and Genomics Research Program$21,078
P30 · FY2016 · CA · contact PI
Cancer Prevention and Control Research Program$18,410
P30 · FY2016 · CA · contact PI
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER$2,185,000
P50 · FY2015 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$791,833
R01 · FY2015 · CA · contact PI
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival$426,443
R01 · FY2015 · CA · contact PI
Administration, Evaluation, and Planning$191,606
P50 · FY2015 · CA · contact PI
Gastrointestinal Malignancies$93,224
P30 · FY2015 · CA · contact PI
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER$2,152,672
P50 · FY2014 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$720,713
R01 · FY2014 · CA · contact PI
Administration, Evaluation, and Planning$180,644
P50 · FY2014 · CA · contact PI
Gastrointestinal Malignancies$88,327
P30 · FY2014 · CA · contact PI
SPORE: DF/HCC SPORE in GASTROINTESTINAL CANCER$2,150,500
P50 · FY2013 · CA · contact PI
Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer$633,285
R01 · FY2013 · CA · contact PI
Administration, Evaluation, and Planning$200,351
P50 · FY2013 · CA · contact PI
Gastrointestinal Malignancies$85,483
P30 · FY2013 · CA · contact PI
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis$736,883
R01 · FY2012 · CA · contact PI
Gastrointestinal Malignancies$93,207
P30 · FY2012 · CA · contact PI
DF/HCC SPORE in Gastrointestinal Cancer$2,185,000
P50 · FY2011 · CA · contact PI
A Prospective Study of Diet and Colorectal Neoplasia$1,243,421
U19 · FY2011 · CA · contact PI
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis$746,660
R01 · FY2011 · CA · contact PI
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival$361,381
R01 · FY2011 · CA · contact PI
Defining Optimal Doses of Vitamin D for Chemoprevention in African Americans$199,286
P50 · FY2011 · CA · contact PI
DF/HCC SPORE in Gastrointestinal Cancer$2,409,374
P50 · FY2010 · CA · contact PI
A Prospective Study of Diet and Colorectal Neoplasia$957,301
U19 · FY2010 · CA · contact PI
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis$949,009
R01 · FY2010 · CA · contact PI
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival$375,317
R01 · FY2010 · CA · contact PI
Defining Optimal Doses of Vitamin D for Chemoprevention in African Americans$219,750
P50 · FY2010 · CA · contact PI
DF/HCC SPORE in Gastrointestinal Cancer$2,387,462
P50 · FY2009 · CA · contact PI
A Prospective Study of Diet and Colorectal Neoplasia$1,114,883
P01 · FY2009 · CA · contact PI
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival$530,050
R01 · FY2009 · CA · contact PI
Defining Optimal Doses of Vitamin D for Chemoprevention in African Americans$217,752
P50 · FY2009 · CA · contact PI
DF/HCC SPORE in Gastrointestinal Cancer$2,300,001
P50 · FY2008 · CA · contact PI
A Prospective Study of Diet and Colorectal Neoplasia$1,089,855
P01 · FY2008 · CA · contact PI
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis$935,521
R01 · FY2008 · CA · contact PI
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival$467,879
R01 · FY2008 · CA · contact PI
Defining Optimal Doses of Vitamin D for Chemoprevention in African Americans$209,772
P50 · FY2008 · CA · contact PI
DF/HCC SPORE in Gastrointestinal Cancer$2,300,001
P50 · FY2007 · CA · contact PI
A Prospective Study of Diet and Colorectal Neoplasia$1,108,179
P01 · FY2007 · CA · contact PI
Prospective Cohort Collaborative in Pancreatic Cancer Epidemiology & Pathogenesis$928,555
R01 · FY2007 · CA · contact PI
Dietary and Lifestyle Determinants of Colon Cancer Recurrence and Survival$421,344
R01 · FY2007 · CA · contact PI
Administration, Evaluation, and Planning$212,777
P50 · FY2007 · CA · contact PI
Defining Optimal Doses of Vitamin D for Chemoprevention in African Americans$190,366
P50 · FY2007 · CA · contact PI
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS$483,863
R01 · FY2004 · CA
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS$653,041
R01 · FY2003 · CA
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS$500,886
R01 · FY2002 · CA
PROSPECTIVE STUDY OF DIET AND COLORECTAL NEOPLASIA$279,549
P01 · FY2002 · CA
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS$500,866
R01 · FY2001 · CA
PROSPECTIVE STUDY OF DIET AND COLORECTAL NEOPLASIA$279,549
P01 · FY2001 · CA
PROSPECTIVE STUDY OF PANCREATIC CANCER PATHOGENESIS$435,532
R01 · FY2000 · CA